Xiaotong Sun
Weifang, 261000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Ozone protects from myocardial ischemia-reperfusion injury via inhibition of the NLRP3 inflammasome.
Ozone protects from myocardial ischemia-reperfusion injury via inhibition of the NLRP3 inflammasome.
Journal: European journal of pharmacology
Published: January 07, 2025
Clemastine fumarate alleviates endoplasmic reticulum stress through the Nur77/GFPT2/CHOP pathway after ischemia/reperfusion in rat hearts.
Journal: International immunopharmacology
Published: August 28, 2024
Propofol pretreatment inhibits ferroptosis and alleviates myocardial ischemia-reperfusion injury through the SLC16A13-AMPK-GPX4 pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 08, 2024
Dexmedetomidine preconditioning attenuates ferroptosis in myocardial ischemia-reperfusion injury via α2 adrenergic receptor activation.
Journal: Heliyon
Published: March 24, 2024
Therapeutic Effects of Salvianolic Acid B on Angiotensin II-Induced Atrial Fibrosis by Regulating Atrium Metabolism via Targeting AMPK/FoxO1/miR-148a-3p Axis.
Journal: Journal of cardiovascular translational research
Published: April 19, 2022
Propofol pretreatment alleviates mast cell degranulation by inhibiting SOC to protect the myocardium from ischemia-reperfusion injury.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 09, 2022
The Efficacy and Safety of Sacubitril/Valsartan in Heart Failure Patients: A Review.
Journal: Journal of cardiovascular pharmacology and therapeutics
Published: January 07, 2022
TSPO Ligands Protect against Neuronal Damage Mediated by LPS-Induced BV-2 Microglia Activation.
Journal: Oxidative medicine and cellular longevity
Published: October 20, 2021
DL-3-n-butylphthalide protects H9c2 cardiomyoblasts from ischemia/reperfusion injury by regulating HSP70 expression via PI3K/AKT pathway activation.
Journal: Experimental and therapeutic medicine
Published: May 20, 2021
Correction to: Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation.
Journal: BMC anesthesiology
Published: May 11, 2021
Last Updated: 09/26/2026